Sarah Challenor

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Northend, William Wilson, Wendy Osborne, Christopher Paul Fox, Andrew John Davies, Dima El-Sharkawi, Elizabeth H Phillips, Hau Wui Sim, Shalal Sadullah, Nimish Shah, Ying Ying Peng, Iman Qureshi, Juanah Addada, Rocio Figueroa Mora, Neil Phillips, Andrea Kuhnl, Elizabeth Davies, David Wrench, Pamela McKay, Indrani Karpha, Anna Cowley, Richard Karim, Sarah Challenor, Vikram Singh, Cathy Burton, Rebecca Auer, Chris Williams, Joel Cunningham, Angus Broom, Anita Arasaretnam, Claire Roddie, Tobias Menne, William Townsend
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL. Blood advances 6 (9) (2022)
Sarah Challenor, David Tucker
SARS-CoV-2-induced remission of Hodgkin lymphoma. British journal of haematology 192 (3) (2021)

Sarah Challenor.css-eqlu8i{font-size:small;padding-left:4px;}